Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |